5398722026-08-12BAJAJHCAREBAJAJ HEALTHCARE LIMITED539872NOTLISTEDINE411U01027Key licenses or regulatory approvals (Sub-para 12-Para B)Newfalse2026-08-1119:27:002026-08-12Regulatory approvalsGrantingDrugs Controller General of IndiaThe Company has received approval from the Drugs Controller General of India (DCGI), under the Central Drugs Standard Control Organisation (CDSCO),for the manufacture and marketing of Cenobamate API and Cenobamate Tablets in strengths of 12.5 mg, 25 mg, 50 mg, 100 mg, 150 mg and 200 mg.The approval enables the Company to manufacture and market Cenobamate API and Cenobamate TabletsIt enables the Company to manufacture and market Cenobamate API and Cenobamate TabletsIt will strengthen the position of the Company as a trusted supplier in the Indian market.Not ApplicableNot ApplicableNot Applicable